Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling. - Wikidata - awgldk - TriplyDB

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.

http://www.wikidata.org/entity/Q36099266

about

Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis.FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.Combinational strategies of metformin and chemotherapy in cancers.Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.Targeting cancer stem cells for chemoprevention of pancreatic cancer.Metformin treatment reduces temozolomide resistance of glioblastoma cells.Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway.Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells.Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines.Leptin signaling and cancer chemoresistance: Perspectives.Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry.Research on human glioma stem cells in China.MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.Targeting FBPase is an emerging novel approach for cancer therapy.Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.Metformin and blood cancers Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation

P2860

Q28816972-5A8880A3-E1E5-49D0-A943-C3A08789170B Q37030873-8F5C68FC-A4EE-4676-91FE-24C208185FD2 Q38375735-732739C5-B21C-4CB6-99C8-05E1D00F3DF3 Q38699316-2A9E5E9F-04A4-4FF9-891F-34818CC355CC Q38742577-9119512F-3AFB-43B2-9C9C-433468AF926D Q38818730-8EDFDDDE-554C-4BD0-ADB4-007D23E98405 Q38829871-E65CECD1-6BE4-4BB8-97C6-2A47B447C233 Q39109832-59241A46-756D-45FA-9710-08147B46DA89 Q39239705-BC0E4412-34EE-41B0-B429-CB830ABF3D1A Q40641258-18F4917A-25A8-4D0B-AA02-E81A0DEA332D Q41345865-8730109E-358B-4115-87B2-FE61277B8814 Q41395916-378FD78B-F29A-46FE-8340-F575776993A7 Q42365079-11170917-F0E4-4856-9B42-5CC68BF725BB Q42374193-BD7A0F69-DCA3-4E4E-B542-D593219837A5 Q47151420-2BECD173-1146-47A7-B69D-7B986F6F9250 Q50294965-C5B8AE38-5C17-474B-BD39-74FD37ED000C Q52647812-7780853F-82B8-4A80-9E9A-D0E16A92B3FC Q55245917-167D671B-927B-4A75-BE36-C77DBB5F11A5 Q58699189-F229ED47-E37A-4480-9C03-3278AA83FF7B Q58800892-0514007C-4F0A-438E-951C-E8F07F503B21

P2860

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.

http://www.wikidata.org/entity/Q36099266

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@ast

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@en

type

label

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@ast

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@en

prefLabel

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@ast

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@en

P1433

Q36099266-1CD3A015-6D7B-4F8B-A2DC-2B96CBB22835

P1476

Q36099266-9CC9A9BF-A926-4F95-9117-5D6DF07B33BE

P2093

Q36099266-283172A9-6F41-48C9-8E9D-17161E666627

Q36099266-4650F5AE-9A95-4751-9143-658B4A077907

Q36099266-5DDF142E-8249-4FF7-9BEE-0CA6CCF078F8

Q36099266-788E8E98-715A-4CD6-B319-16699FBA2735

Q36099266-D5C1F35A-AC56-4879-A037-90DA77DC0D99

Q36099266-FCD96CF7-ACC4-4A33-A241-EC3143A51BFF

P2860

Q36099266-05DC81C6-EC31-4E40-A518-F489EA11BBBE

Q36099266-0C5AC389-9E1B-4760-9D7C-4A1BB6EED308

Q36099266-11750904-1CCA-455B-BB5A-AE08D6968365

Q36099266-1515FE60-AAC1-4F24-B213-339625559769

Q36099266-1E97119C-1BDE-4AC9-81D3-7F9CC04194E0

Q36099266-227AF2C9-EE2D-49D8-A090-B1D16F4BA485

Q36099266-295C27BC-E04C-42F7-A9A6-E839A340A1B4

Q36099266-2B1BA916-52FA-4218-8073-26C348F88E69

Q36099266-303108EE-50EE-4F9B-BF35-6676B408145E

Q36099266-34B7290B-AB07-422C-A182-014B36E11B1B

P2888

Q36099266-BFE1E5BF-8CC2-464D-BF4D-EDD85507796A

P304

Q36099266-2D6BD524-D3A0-4C26-97E4-70C8FB5587CF

P31

Q36099266-F6381D3E-3349-457C-ABE6-4EF21B21E0B1

P356

Q36099266-1A8BE926-732C-42A0-BDD1-87CA9882C199

P407

Q36099266-D835C95C-E728-46EB-AC93-6741BCBC110F

P478

Q36099266-E305C375-72DD-435B-BAEE-99C47F73E458

P577

Q36099266-0748C43E-50DD-4C91-80E2-E817EFE97DF3

P5875

Q36099266-2E580820-BEF3-4DBF-AA5B-1C80A4CADE8B

P6179

Q36099266-6EC2BCD1-FFF2-440D-BACB-6934A93B9E4C

P698

Q36099266-9562007E-8611-4406-A578-BE829551FC96

P921

Q36099266-23C25E7C-209C-4E70-8798-B9F5BEB36BFA

P932

Q36099266-17CDD271-E64D-4F82-A6E5-8DC11099C2CC

P356

P1433

Scientific Reports

P1476

Metformin Increases Sensitivit ...... pressing ERK/P70S6K Signaling.

@en

P2093

Hongpeng Chu

http://www.w3.org/2001/XMLSchema#string

Pengfei Shi

http://www.w3.org/2001/XMLSchema#string

Shanmiao Gou

http://www.w3.org/2001/XMLSchema#string

Xinqun Chai

http://www.w3.org/2001/XMLSchema#string

Xuan Yang

http://www.w3.org/2001/XMLSchema#string

Yuanpu Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Cellular and molecular mechanisms of metformin: an overview

Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.

Cancer statistics, 2013

Chemoprevention for pancreatic cancer

Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action

Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells

Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

P2888

P304

14404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP14404

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282127899

http://www.w3.org/2001/XMLSchema#string

P6179

1014052737

http://www.w3.org/2001/XMLSchema#string

P698

26391180

http://www.w3.org/2001/XMLSchema#string

P921

P932

4585731

http://www.w3.org/2001/XMLSchema#string